Product Code: ETC332649 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The meningococcal vaccines market covers vaccines used to protect against meningococcal disease, a serious bacterial infection. This market includes the development, production, and distribution of vaccines to prevent outbreaks and protect public health.
In the UK, the meningococcal vaccines market growth is driven by public health initiatives, vaccination programs, and advancements in vaccine technologies. Demand is influenced by outbreaks, epidemiological surveillance, and healthcare policies aimed at preventing meningococcal disease among children and young adults.
Similarly, challenges in the Meningococcal Vaccines market include addressing vaccine efficacy against evolving meningococcal strains and optimizing immunization strategies for diverse population groups. Regulatory compliance with vaccine safety standards and global vaccination campaigns demand extensive clinical trials and regulatory approvals. Market players must navigate through healthcare policy reforms and vaccine supply chain logistics while addressing public health concerns and vaccine hesitancy, influencing market access and adoption rates.
Government policies in the UK focus on public health immunization programs and vaccine safety in the meningococcal vaccines market. Regulatory frameworks oversee vaccine production standards and immunization schedules to prevent disease outbreaks and protect public health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Meningococcal Vaccines Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Meningococcal Vaccines Market - Industry Life Cycle |
3.4 United Kingdom (UK) Meningococcal Vaccines Market - Porter's Five Forces |
3.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Meningococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing meningococcal disease |
4.2.2 Government initiatives and vaccination programs to increase immunization rates |
4.2.3 Rising incidence of meningococcal disease in the UK |
4.3 Market Restraints |
4.3.1 High cost of meningococcal vaccines leading to affordability issues for some individuals or families |
4.3.2 Vaccine hesitancy and misinformation affecting vaccination rates |
4.3.3 Regulatory challenges and approval processes for new meningococcal vaccines |
5 United Kingdom (UK) Meningococcal Vaccines Market Trends |
6 United Kingdom (UK) Meningococcal Vaccines Market, By Types |
6.1 United Kingdom (UK) Meningococcal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021-2031F |
6.1.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2021-2031F |
6.2 United Kingdom (UK) Meningococcal Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Infants, 2021-2031F |
6.2.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Children, 2021-2031F |
6.2.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2021-2031F |
6.2.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Adults, 2021-2031F |
6.3 United Kingdom (UK) Meningococcal Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2021-2031F |
6.3.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2021-2031F |
6.3.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2021-2031F |
6.3.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Others, 2021-2031F |
7 United Kingdom (UK) Meningococcal Vaccines Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Meningococcal Vaccines Market Export to Major Countries |
7.2 United Kingdom (UK) Meningococcal Vaccines Market Imports from Major Countries |
8 United Kingdom (UK) Meningococcal Vaccines Market Key Performance Indicators |
8.1 Number of individuals vaccinated against meningococcal disease |
8.2 Percentage of infants and children receiving recommended meningococcal vaccinations |
8.3 Rate of meningococcal disease cases in the UK |
8.4 Funding allocated towards meningococcal vaccination programs |
8.5 Public perception and sentiment towards meningococcal vaccines |
9 United Kingdom (UK) Meningococcal Vaccines Market - Opportunity Assessment |
9.1 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Meningococcal Vaccines Market - Competitive Landscape |
10.1 United Kingdom (UK) Meningococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |